ViiV Healthcare

This site is intended for US healthcare professionals only.

ALL EVENTS

Read more »

APRETUDE

(cabotegravir 200 mg/mL)

extended-release injectable suspension

Read more »

DOVATO

(dolutegravir 50 mg and

lamivudine 300 mg) tablets

Read more »

CABENUVA

(cabotegravir 200 mg/mL; rilpivirine 300 mg/mL)

extended-release injectable suspensions

Read more »

RUKOBIA

(fostemsavir 600 mg)

extended-release tablets

Read more »

Stay up-to-date
on our
Virtual Offerings
and Events

Icon: Arrow Scroll Down
Logo: Apretude

All APRETUDE Events See full Prescribing Information, including Boxed Warning, for APRETUDE.

Logo: Dovato

All DOVATO Events See full Prescribing Information, including Boxed Warning, for DOVATO.

Logo: Cabenuva

All CABENUVA Events See full Prescribing Information for CABENUVA.

Logo: Rukobia

All RUKOBIA Events See full Prescribing Information for RUKOBIA.

To report SUSPECTED ADVERSE REACTIONS,
contact ViiV Healthcare at
1-877-844-8872 or FDA at
1-800-FDA-1088 or www.fda.gov/medwatch.

ViiV Healthcare Logo

Trademarks are owned by or
licensed to the ViiV Healthcare group of companies.
This site is funded and developed by ViiV Healthcare.
This site is intended for US healthcare professionals only.
©2021 ViiV Healthcare or licensor.
CBTWCNT210027 November 2021
Produced in USA.

Terms of Use | Privacy Notice | Patient Support |
Contact Us | ViiV Medical Information